Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-20.51%
↑ 65% vs avg
Percentile
P83
Within normal range
Streak
4 yr
Consecutive growthAccelerating
Average
-58.49%
Historical baseline
PeriodValue
2025-20.51%
2024-38.89%
2023-59.59%
2022-65.82%
2021-151.37%
2020-73.24%
20190.00%